Legal status · United States
Is Melanotan I legal in the United States?
Yes. Melanotan I is an approved medicine in the United States, classified as "FDA-approved for a specific indication, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Melanotan I in the United States at a glance
| Classification | FDA-approved for a specific indication, prescription only |
|---|---|
| FDA approval status | FDA-approved (Scenesse) for erythropoietic protoporphyria |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Melanotan I profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Melanotan I for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Melanotan I is
An FDA-approved melanocortin agonist that increases skin pigmentation to protect people with a rare light-sensitivity disorder.
Melanotan I, or afamelanotide, is a melanocortin receptor agonist approved by the FDA in 2019 as Scenesse. It is used to increase pain-free light exposure in adults with erythropoietic protoporphyria, a rare inherited condition of severe skin light sensitivity, by stimulating protective pigmentation.
Mechanism: Agonizes the melanocortin-1 receptor to stimulate eumelanin production, increasing photoprotective skin pigmentation.
Regulatory history: FDA-approved (Scenesse) for erythropoietic protoporphyria
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Melanotan I at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Melanotan I in other countries
United Kingdom
Approved medicineLicensed (EU/UK) for erythropoietic protoporphyria
Is Melanotan I legal in the United Kingdom?Australia
Approved medicineTGA-registered for erythropoietic protoporphyria
Is Melanotan I legal in Australia?Canada
Approved medicineApproved for erythropoietic protoporphyria
Is Melanotan I legal in Canada?Frequently asked questions
Is Melanotan I legal in the United States?
Yes. Melanotan I is an approved medicine in the United States, classified as "FDA-approved for a specific indication, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Melanotan I in the United States?
Only with a prescription. Melanotan I is classified as "FDA-approved for a specific indication, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Melanotan I FDA approved?
Yes. FDA status: FDA-approved (Scenesse) for erythropoietic protoporphyria. Current US classification: "FDA-approved for a specific indication, prescription only". Evidence level: Strong.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Melanotan I live on its compound profile.
Melanotan I profileThis page is general information about the regulatory status of Melanotan I in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.